277 related articles for article (PubMed ID: 32123069)
1. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Kong FE; Tang YQ; Gong YF; Mo JQ; Zhao Y; Li MM; Cheng W; Li HL; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
Hepatol Int; 2020 Jul; 14(4):521-533. PubMed ID: 32304089
[TBL] [Abstract][Full Text] [Related]
3. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
5. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of
Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
[TBL] [Abstract][Full Text] [Related]
8. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway.
Zhu JN; Jiang L; Jiang JH; Yang X; Li XY; Zeng JX; Shi RY; Shi Y; Pan XR; Han ZP; Wei LX
Sci Rep; 2017 Jul; 7(1):4793. PubMed ID: 28684878
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
13. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
14. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
Li MM; Tang YQ; Gong YF; Cheng W; Li HL; Kong FE; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
BMC Cancer; 2019 Aug; 19(1):851. PubMed ID: 31462277
[TBL] [Abstract][Full Text] [Related]
15. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy.
Dolicka D; Sobolewski C; Gjorgjieva M; Correia de Sousa M; Berthou F; De Vito C; Colin DJ; Bejuy O; Fournier M; Maeder C; Blackshear PJ; Rubbia-Brandt L; Foti M
Cell Mol Gastroenterol Hepatol; 2021; 11(2):597-621. PubMed ID: 32987153
[TBL] [Abstract][Full Text] [Related]
16. Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection.
Ma X; Gu J; Wang K; Zhang X; Bai J; Zhang J; Liu C; Qiu Q; Qu K
Sci Rep; 2019 May; 9(1):7073. PubMed ID: 31068611
[TBL] [Abstract][Full Text] [Related]
17. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652
[TBL] [Abstract][Full Text] [Related]
18. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling.
Peng JM; Tseng RH; Shih TC; Hsieh SY
Cancer Lett; 2021 Jan; 497():66-76. PubMed ID: 33068700
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
20. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.
Hu M; Wang M; Lu H; Wang X; Fang X; Wang J; Ma C; Chen X; Xia H
Oncotarget; 2016 Jul; 7(28):43419-43431. PubMed ID: 27270326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
